Protective role of the L-arginine-nitric oxide synthase pathway on preservation injury after rat liver transplantation

Journal of Parenteral and Enteral Nutrition

Volumn 25, Issue 3, 2001, Pages 142-147

  Geller, D A ^a   Chia, S H ^a   Takahashi, Y ^a   Yagnik, G P ^a   Tsoulfas, G ^a   Murase, N ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ARGININE; LIVER ENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; GRAFT REJECTION; INFECTION; INFLAMMATION; LIVER FUNCTION TEST; LIVER ISCHEMIA; LIVER PRESERVATION; LIVER PROTECTION; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SUPPLEMENTATION;

EID: 0035033402     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607101025003142     Document Type: Article

References (56)

1. Sinusoidal lining cell damage: The critical injury in cold preservation of liver allografts in the rat
2. Reperfusion injury to endothelial cells following cold ischemic storage of rat livers
3. Activation of nuclear factor-kappaB during orthotopic liver transplantation in rats is protective and does not require Kupffer cells
4. Molecular biology of nitric oxide synthases
5. Cytokines, endotoxins, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
6. A central role for IL-1b in the in vitro and in vivo regulation of hepatic inducible nitric oxide synthase. IL-1b induces hepatic nitric oxide synthesis
7. Role of endogenous nitric oxide in ischemia-reperfusion injury in rat liver
8. Beneficial effects of FK409, a novel nitric oxide donor, on reperfusion injury of rat liver
9. Role of exogenous L-arginine in hepatic ischemia-reperfusion injury
10. Protective role of nitric oxide in ischemia and reperfusion injury of the liver
11. The protective effects of L-arginine after liver ischaemia/reperfusion injury in a pig model
12. Protective effect of L-arginine on liver ischemia-reperfusion injury
13. Improvement of cardiac output and liver blood flow and reduction of pulmonary vascular resistance by intravenous infusion of L-arginine during the early reperfusion period in pig liver transplantation
14. Cytokine-induced synthesis of nitrogen oxides in macrophages: A protective host response to Leishmania and other intracellular pathogens
15. Nitric oxide: An endogenous modulator of leukocyte adhesion
16. Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine
17. Modulation of nitric oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage
18. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen radical-mediated hepatic injury
19. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells
20. Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat
21. Adenovirus-mediated iNOS gene transfer inhibits hepatocyte apoptosis
22. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-induced apoptosis and toxicity in the liver
23. Differential effects of non-selective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia
24. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
25. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
26. Nitric oxide suppression of apoptosis occurs in association with an inhibition of Bcl-2 cleavage and cytochrome c release
27. A surgical experience with five hundred thirty liver transplants in the rat
28. Evidence for increased nitric oxide production after liver transplantation in humans
29. Nitric oxide generation. A predictive parameter of acute allograft rejection
30. L-arginine deficiency after liver transplantation as an effect of arginase efflux from the graft. Influence on nitric oxide metabolism
31. Nitric oxide synthesis in the in vivo allograft response: A possible regulatory mechanism
32. Nitric oxide production by mouse sponge matrix allograft-infiltrating cells
33. EPR detection of heme and nonheme iron-containing protein nitrosylation by nitric oxide during rejection of the rat heart allograft
34. Nitric oxide production in host-versus-graft and graft-versus-host reactions in the rat
35. Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats
36. Cellular localization and effect of nitric oxide synthesis in a rat model of orthotopic liver transplantation
37. Extended preservation and effect of nitric oxide production in liver transplantation
38. Role of sodium nitroprusside in the improvement of rat liver preservation in University of Wisconsin solution: A study in the isolated perfused liver model
39. The nitric oxide/cyclic GMP pathway in organ transplantation: Critical role in successful lung preservation
40. Inhaled nitric oxide attenuates reperfusion injury in non-heartbeating-donor lung transplantation
41. Localization of inducible nitric oxide synthase in acute renal allograft rejection in the rat
42. Nitric oxide synthase activity in renal ischemia-reperfusion injury in the rat: Implications for renal transplantation
43. Protective effect of exogenous nitric oxide on the renal function and inflammatory response in a model of ischemia-reperfusion
44. The nitric oxide donor sodium nitroprusside is protective in ischemia/reperfusion injury of the pancreas
45. Nitric oxide donors improve gut function after prolonged hypothermic ischemia
46. The effects of administration of nitric oxide inhibitors during small bowel preservation and reperfusion
47. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
48. Induction of myocardial nitric oxide synthase by cardiac allograft rejection
49. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle
50. Allograft rejection
51. N-omega-monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection
52. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase
53. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival
54. Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografts in the rat
55. Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis
56. Inducible nitric oxide synthase suppresses development of allograft arteriosclerosis